Evidence map›Paper›PMID 20618396›Full record

ReviewEpilepsia2010

Modeling new therapies for infantile spasms.

Lenka Chudomelova, Morris H Scantlebury, Emmanuel Raffo, Antonietta Coppola, David Betancourth, Aristea S Galanopoulou

Open access · bronzeAbstract readReview
In one paragraph

Review in Epilepsia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Frontiers in neurology · 2018
    Article
  5. Inflammation in Epileptic Encephalopathies.Advances in protein chemistry and structural biology · 2017
    Review
  6. Review
  7. Article
  8. Issues for new antiepilepsy drug development.Current opinion in neurology · 2013
    Review
  9. Latest American and European updates on infantile spasms.Current neurology and neuroscience reports · 2013
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lenka ChudomelovaSaul R Korey Department of Neurology and Montefiore/Einstein Epilepsy Management Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Morris H Scantlebury
Emmanuel Raffo
Antonietta Coppola
David Betancourth
Aristea S Galanopoulou
Charles University · CZ

Funding

AGE RELATED SEIZURE SUPPRESSIONR01NS020253 · NINDS · YESHIVA UNIVERSITY · PI MOSHE, SOLOMON L. · 1985 to 2011
$4.7M
Sexual dimorphism in seizure control is KCC2 mediatedK08NS045243 · NINDS · YESHIVA UNIVERSITY · PI GALANOPOULOU, ARISTEA S · 2003 to 2007
$864k
The role of brainstem in the generation of infantile spasmsK02NS062947 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI GALANOPOULOU, ARISTEA S · 2008 to 2010
$572k
Age related seizure suppressionR56NS020253 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI MOSHE, SOLOMON L. · 2007 to 2007
$498k
A new animal model of infantile spasmsR21NS058303 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI MOSHE, SOLOMON L. · 2007 to 2008
$397k
NINDS NIH HHS K02 NS062947NINDS NIH HHS K08 NS045243NINDS NIH HHS NS20253NINDS NIH HHS NS45243NINDS NIH HHS NS58303NINDS NIH HHS NS62947NINDS NIH HHS R01 NS020253NINDS NIH HHS R21 NS058303NINDS NIH HHS R56 NS020253
6 · The paper itself

Abstract

Infantile spasms are the classical seizure type of West syndrome. Infantile spasms often herald a dismal prognosis, due to the high probability to evolve into intractable forms of epilepsies with significant cognitive deficits, especially if not adequately treated. The current therapies-high doses of adrenocorticotropic hormone, steroids, or the gamma-aminobutyric acid (GABA) transaminase inhibitor vigabatrin--are often toxic and may not always be effective. The need to identify new therapies for spasms has led to the generation of a number of rodent models of infantile spasms. These include acute and chronic models of infantile spasms, with cryptogenic or symptomatic origin, many of which are based on specific etiologies. In this review, we summarize the clinical experience with treating infantile spasms and the main features of the new animal models of infantile spasms and discuss their utility in the preclinical development of new therapies for infantile spasms.

Indexed as

Adrenocorticotropic HormoneAnimalsAnticonvulsantsDisease Models, AnimalHumansInfantMiceRatsReceptors, GABASirolimusSpasms, InfantileVigabatrinAdrenocorticotropic HormoneAnticonvulsantsReceptors, GABASirolimusVigabatrin

Identifiers

PMID20618396
PMCPMC2909007
OpenAlexW1593502927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.